# OrbusNeich breaks ground on R&D and production base in Hangzhou

OrbusNeich held a groundbreaking ceremony for its new R&D and production base in Fuyang, Hangzhou, China, with fixed asset investment of approximately RMB 300-400 million. The facility will have a gross floor area of 60,000 m² and focus on PCI and PTA interventional products.

- Type: New facility
- Announced: 2023-12-03
- Where: Fuyang, Hangzhou, China
- Value: $49.0M (350.0M CNY)
- Status: under construction
- Capacity: 60,000 m² gross floor area
- Products: PCI and PTA interventional products, structural heart disease interventional products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OrbusNeich Medical](https://endata.com/companies/69366.md)

## Sources

- [orbusneich.com](https://orbusneich.com/orbusneich-holds-groundbreaking-ceremony-for-rd-and-production-base-in-fuyang-hangzhou/), 2023-12-04: "The groundbreaking ceremony of our new R&D and production base in Hangzhou marks another important milestone in the business development."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.